122 related articles for article (PubMed ID: 7796835)
21. Polyneuropathy associated with IgM monoclonal gammopathy: a review. Clinical, electrophysiological and pathological features.
Leger JM; Vaunaize J
Nouv Rev Fr Hematol (1978); 1990; 32(5):303-6. PubMed ID: 1965990
[TBL] [Abstract][Full Text] [Related]
22. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
Fisher MA; Wilson JR
Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
[TBL] [Abstract][Full Text] [Related]
23. Motor neuron disease and plasma cell dyscrasia.
Shy ME; Rowland LP; Smith T; Trojaborg W; Latov N; Sherman W; Pesce MA; Lovelace RE; Osserman EF
Neurology; 1986 Nov; 36(11):1429-36. PubMed ID: 3762961
[TBL] [Abstract][Full Text] [Related]
24. Fracture risk in monoclonal gammopathy of undetermined significance.
Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
[TBL] [Abstract][Full Text] [Related]
25. [Monoclonal gammopathy of uncertain significance in rheumatic disease].
Broggini M; Cavallo A; Baratelli E; Volonté S; Crespi E; Cappelli A; Chelazzi G
Recenti Prog Med; 1990 May; 81(5):306-9. PubMed ID: 2377807
[TBL] [Abstract][Full Text] [Related]
26. [Paraproteinemic neuropathies: foundations for a specific therapy related to patients' quality of life].
Casadevall Codina T; Pérez Lázaro C; Santos S; Fabre Pi O; Garcés Redondo M; Larrodé Pellicer P
Rev Neurol; 2004 Apr 1-15; 38(7):631-6. PubMed ID: 15098183
[TBL] [Abstract][Full Text] [Related]
27. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Dyck PJ; Low PA; Windebank AJ; Jaradeh SS; Gosselin S; Bourque P; Smith BE; Kratz KM; Karnes JL; Evans BA
N Engl J Med; 1991 Nov; 325(21):1482-6. PubMed ID: 1658648
[TBL] [Abstract][Full Text] [Related]
28. Presence of crystalline inclusions in the peripheral nerve of a patient with IgA lambda monoclonal gammopathy of undetermined significance.
Vital A; Nedelec-Ciceri C; Vital C
Neuropathology; 2008 Oct; 28(5):526-31. PubMed ID: 18410274
[TBL] [Abstract][Full Text] [Related]
29. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
30. IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS.
Shelly S; Mills JR; Martinez-Thompson JM; Rofforth MM; Pittock SJ; Mandrekar J; Triplett JD; Mauermann M; Dubey D; Klein CJ
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):324-326. PubMed ID: 31757814
[No Abstract] [Full Text] [Related]
31. Motor neuron disease of paraneoplastic origin: a rare but treatable condition.
Mélé N; Berzero G; Maisonobe T; Salachas F; Nicolas G; Weiss N; Beaudonnet G; Ducray F; Psimaras D; Lenglet T
J Neurol; 2018 Jul; 265(7):1590-1599. PubMed ID: 29725842
[TBL] [Abstract][Full Text] [Related]
32. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
Saito T
Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
[TBL] [Abstract][Full Text] [Related]
33. Motor neuron syndromes in cancer patients.
Forsyth PA; Dalmau J; Graus F; Cwik V; Rosenblum MK; Posner JB
Ann Neurol; 1997 Jun; 41(6):722-30. PubMed ID: 9189033
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan.
Iwanaga M; Tagawa M; Tsukasaki K; Kamihira S; Tomonaga M
Mayo Clin Proc; 2007 Dec; 82(12):1474-9. PubMed ID: 18053454
[TBL] [Abstract][Full Text] [Related]
35. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal gammopathy in a tertiary referral hospital.
Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal gammopathy in search of clinical significance: 57 years later.
Go RS; Doyle LM
Blood; 2009 Sep; 114(11):2355-6; author reply 2356-7. PubMed ID: 19745077
[No Abstract] [Full Text] [Related]
38. Prevalence of monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
[TBL] [Abstract][Full Text] [Related]
39. [Lower motor neuron disease and signs of dysimmunity].
Azulay JP; Attarian S; Boucraut J; Pouget J
Rev Neurol (Paris); 2000 Apr; 156(4):372-9. PubMed ID: 10795014
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement.
Asatiani E; Cohen P; Ozdemirli M; Kessler CM; Mavromatis B; Cheson BD
Am J Hematol; 2004 Oct; 77(2):144-6. PubMed ID: 15389912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
